Prime presents at: PBMI MAP Forum - Prime Therapeutics LLC

Advances in Oncology Management

Event/registration:

2024 PBMI MAP Forum

Date/time:

Friday, March 8, 10:00 – 10:50 AM ET

Prime/Magellan Rx participants:

Simone Ndujiuba, Director, Clinical Strategy and Innovation, Oncology

About Prime Therapeutics + Magellan Rx

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Events

September 16, 2024

Prime presents: Specialty Summit 2024

From Sept. 16–18, 2024, the 21st annual event will connect, elevate and transform relationships, with exceptional speakers, insightful panels and in-person networking, helping to build the future of specialty

Events

August 14, 2024

Prime presents at: Medicaid Enterprise Systems Community (MESC) conference 2024

Educational session on Aug. 14 details the management of Medicaid pharmacy spend and maximizing technology to support state efforts

Events

August 8, 2024

Prime presents at: Disability:IN Minnesota’s August Member Meeting

Join us on Aug. 8 for a virtual conversation on how ERGs and BRGs can create more inclusive workplaces at Disability:IN Minnesota's August Member Meeting

View all news